Lord, Abbett & Co’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-151,225
Closed -$27.3M 546
2025
Q1
$27.3M Sell
151,225
-64,403
-30% -$11.6M 0.1% 237
2024
Q4
$33.8M Sell
215,628
-68,531
-24% -$10.7M 0.11% 234
2024
Q3
$51.7M Sell
284,159
-108,079
-28% -$19.7M 0.16% 173
2024
Q2
$72M Sell
392,238
-99,994
-20% -$18.4M 0.24% 116
2024
Q1
$87.6M Sell
492,232
-126,226
-20% -$22.5M 0.28% 107
2023
Q4
$76.7M Sell
618,458
-52,853
-8% -$6.56M 0.27% 108
2023
Q3
$77.9M Sell
671,311
-171,337
-20% -$19.9M 0.29% 98
2023
Q2
$98.9M Sell
842,648
-118,594
-12% -$13.9M 0.34% 84
2023
Q1
$77M Sell
961,242
-316,780
-25% -$25.4M 0.28% 107
2022
Q4
$101M Buy
1,278,022
+66,081
+5% +$5.23M 0.36% 76
2022
Q3
$84.5M Buy
1,211,941
+94,375
+8% +$6.58M 0.31% 89
2022
Q2
$73.4M Sell
1,117,566
-61,247
-5% -$4.02M 0.26% 110
2022
Q1
$78.4M Buy
1,178,813
+4,950
+0.4% +$329K 0.21% 137
2021
Q4
$82.1M Buy
1,173,863
+106,705
+10% +$7.46M 0.19% 169
2021
Q3
$55.7M Sell
1,067,158
-124,422
-10% -$6.5M 0.13% 235
2021
Q2
$81M Sell
1,191,580
-194,063
-14% -$13.2M 0.2% 157
2021
Q1
$107M Buy
1,385,643
+1,271,267
+1,111% +$97.9M 0.27% 104
2020
Q4
$6.86M Sell
114,376
-2,987
-3% -$179K 0.02% 580
2020
Q3
$5.05M Sell
117,363
-24,297
-17% -$1.05M 0.02% 565
2020
Q2
$5.87M Sell
141,660
-74,932
-35% -$3.1M 0.02% 556
2020
Q1
$9.37M Buy
216,592
+53,851
+33% +$2.33M 0.04% 448
2019
Q4
$9.01M Sell
162,741
-55,009
-25% -$3.05M 0.03% 539
2019
Q3
$7.56M Buy
+217,750
New +$7.56M 0.03% 581